Integrated BioPharma Inc (INBP)
OTHER OTC:INBP
Want to see INBP full AI Analyst Report?
INBP Stock Chart & Stats
$0.34
$0.02(5.88%)
At close: 4:00 PM EST
$0.34
$0.02(5.88%)
Day’s Range― - ―
52-Week Range$0.21 - $0.42
Previous CloseN/A
Volume200.00
Average Volume (3M)15.15K
Market Cap
$7.84M
Enterprise Value$2.79M
Total Cash (Recent Filing)$5.31M
Total Debt (Recent Filing)$649.00K
Price to Earnings (P/E)―
Beta-0.10
Next Earnings
May 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding31,059,610
10 Day Avg. Volume31,065
30 Day Avg. Volume15,153
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.53
Price to Sales (P/S)0.20
P/FCF Ratio5.77
Enterprise Value/Market Cap0.36
Enterprise Value/Revenue0.05
Enterprise Value/Gross Profit0.69
Enterprise Value/Ebitda1.53
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage Balance SheetA very low debt load and conservative balance sheet provide durable financial flexibility. With minimal interest obligations the company can absorb revenue volatility, maintain operations through downturns, and has optionality to fund working capital, capex or opportunistic M&A without immediate refinancing pressure.
Positive Free Cash FlowConsistent positive operating and free cash flow, and recent FCF growth, create a lasting ability to fund operations and reinvest in manufacturing capabilities. Reliable cash generation reduces dependency on external financing and helps sustain capex, working capital, and creditor confidence over months ahead.
Integrated Manufacturing + Distribution ModelA dual model—contract manufacturing plus distribution—provides structural diversification of revenue and multiple margin levers. Vertical capabilities (formulation, packaging, distribution) enable cross-selling, closer customer relationships and capture of both manufacturing fees and distribution spreads over the medium term.
Bears Say
Sharp Revenue Decline & Return To LossA steep TTM revenue drop and a swing to net loss materially reduce operational scale and margin absorption. Persisting top-line weakness makes fixed costs harder to cover, limits reinvestment capacity, and raises execution risk for any turnaround given the dependence on sustaining contract volumes or distribution sales.
Low And Falling Gross MarginsNear‑single-digit gross margins constrain the company's ability to absorb input cost inflation or competitive pricing pressure. Low gross profitability reduces operating leverage, limits reinvestment in differentiation, and leaves little buffer against further volume declines or rising SG&A costs over the medium term.
Volatile Cash Conversion & Operating PerformanceHistorical swings in cash conversion indicate exposure to working-capital swings and non-cash items, increasing financing variability. That volatility raises the risk that episodic cash drains will recur, complicating planning, raising refinancing needs, and undermining the durability of positive free cash flow if revenues remain unstable.
Integrated BioPharma News
INBP FAQ
What was Integrated BioPharma Inc’s price range in the past 12 months?
Integrated BioPharma Inc lowest stock price was $0.20 and its highest was $0.42 in the past 12 months.
What is Integrated BioPharma Inc’s market cap?
Integrated BioPharma Inc’s market cap is $7.84M.
When is Integrated BioPharma Inc’s upcoming earnings report date?
Integrated BioPharma Inc’s upcoming earnings report date is May 07, 2026 which is tomorrow.
How were Integrated BioPharma Inc’s earnings last quarter?
Integrated BioPharma Inc released its earnings results on Feb 11, 2026. The company reported -$0.024 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.024.
Is Integrated BioPharma Inc overvalued?
According to Wall Street analysts Integrated BioPharma Inc’s price is currently Overvalued.
Does Integrated BioPharma Inc pay dividends?
Integrated BioPharma Inc does not currently pay dividends.
What is Integrated BioPharma Inc’s EPS estimate?
Integrated BioPharma Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Integrated BioPharma Inc have?
Integrated BioPharma Inc has 31,059,610 shares outstanding.
What happened to Integrated BioPharma Inc’s price movement after its last earnings report?
Integrated BioPharma Inc reported an EPS of -$0.024 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3%.
Which hedge fund is a major shareholder of Integrated BioPharma Inc?
Currently, no hedge funds are holding shares in INBP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Integrated BioPharma Inc
Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized healthcare providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.
Technical Analysis
Natural Alternatives International
―
Sow Good
―
FitLife Brands
―
Bon Natural Life
―
Healthy Choice Wellness Corp. Class A
―
Ownership Overview
Options Prices
Currently, No data available
---